Xiaoteng Cui

机构：Tianjin Medical University General Hospital, Ministry of Education, Ministry of Education, Tianjin Medical University · ORCID：0000-0003-4994-147X

发表论文 55 篇 · 总被引 1721 次 · h-index 24

代表论文

• Blood exosomes-based targeted delivery of cPLA2 siRNA and metformin to modulate glioblastoma energy metabolism for tailoring personalized therapy (2022 · Neuro-Oncology · 被引 121)
• A novel compound EPIC-0412 reverses temozolomide resistance via inhibiting DNA repair/MGMT in glioblastoma (2022 · Neuro-Oncology · 被引 64)
• Blockage of EGFR/AKT and mevalonate pathways synergize the antitumor effect of temozolomide by reprogramming energy metabolism in glioblastoma (2023 · 癌症：英文版 · 被引 58)
• HIF1α/ATF3 partake in PGK1 K191/K192 succinylation by modulating P4HA1/succinate signaling in glioblastoma (2024 · Neuro-Oncology · 被引 55)
• CRISPR-Cas9 library screening combined with an exosome-targeted delivery system addresses tumorigenesis/TMZ resistance in the mesenchymal subtype of glioblastoma (2024 · Theranostics · 被引 41)
• MUC1 promotes glioblastoma progression and TMZ resistance by stabilizing EGFRvIII (2022 · Pharmacological Research · 被引 35)